In addition, c.100delC heterozygosity has been associated with even higher risk of breast cancer in women with a family history of breast cancer [5], but also with a younger age of breast cancer onset [5], increased risk of bilateral breast cancers [6,7], and worse prognosis among women with estrogen receptor (ER)-positive cases [6]. Here, ESR1 is linked to breast cancer.